Literature DB >> 9233693

Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes.

Y Ilan1, N Roy-Chowdhury, R Prakash, V Jona, P Attavar, C Guha, K Tada, J Roy-Chowdhury.   

Abstract

An important consideration in application of hepatocyte transplantation is whether the number of engrafted hepatocytes is sufficient to achieve the desired effect. Here we have evaluated the proliferative potential of transplanted primary hepatocytes during regeneration of hepatic lobes. Two million hepatocytes isolated from congeneic normal Wistar-RHA rats were injected into the main portal vein of deficient, jaundiced Gunn rats. The right branch of the portal vein was ligated 24 hr before hepatocyte transplantation (group A) or transiently clamped during hepatocyte injection (group B) or 24 hr after hepatocyte injection (group C). In these groups, the three lobes supplied by the right branch of the portal vein rapidly atrophied and disappeared in 4 days, whereas the remaining lobes proliferated, as shown by size increase and 5-bromo-2-deoxy-uridine uptake. Two control groups received 2 million (group D) or 20 million hepatocytes (group E) without ligation. Hepatocyte engraftment occurred in all groups. The greatest hypobilirubinemic effect was observed in group A, in which serum bilirubin concentrations were reduced to 1.7+/-0.45 mg/dl from pretransplantation levels of 6.9+/-1.2 mg/dl. This effect was even greater than that observed after transplantation of 20 times more hepatocytes without ligation (group E). Specific endonuclease digestion of a polymerase chain reaction-amplified segment of the ugt1 gene from hepatic DNA showed that up to 25% of the DNA was of donor origin. This paralleled the hepatic bilirubin-UDP-glucuronosyltransferase activity, which was above 50% of normal. The results indicate that the transplanted hepatocytes proliferate preferentially within the regenerating lobes, replacing more than 20% of the liver mass with the progeny of the transplanted phenotypically normal hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233693     DOI: 10.1097/00007890-199707150-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Hepatocyte Transplantation: Quo Vadis?

Authors:  Mark Barahman; Patrik Asp; Namita Roy-Chowdhury; Milan Kinkhabwala; Jayanta Roy-Chowdhury; Rafi Kabarriti; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-29       Impact factor: 7.038

Review 2.  Liver repopulation: a new concept of hepatocyte transplantation.

Authors:  Yujo Kawashita; Chandan Guha; Kosho Yamanouchi; Yuichiro Ito; Yukio Kamohara; Takashi Kanematsu
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Hepatocyte transplantation: studies in preclinical models.

Authors:  Anne Weber; Dominique Mahieu-Caputo; Michelle Hadchouel; Dominique Franco
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide.

Authors:  B T Kren; B Parashar; P Bandyopadhyay; N R Chowdhury; J R Chowdhury; C J Steer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 5.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

6.  Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation.

Authors:  Kosho Yamanouchi; Hongchao Zhou; Namita Roy-Chowdhury; Frank Macaluso; Liping Liu; Toshiyuki Yamamoto; Govardhana Rao Yannam; Charles Enke; Timothy D Solberg; Anthony B Adelson; Jeffrey L Platt; Ira J Fox; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.